Genmab A/S

GMAB stock score: 67/100

$40.00 · +1.09% · Scored Oct 22, 2026

Technical
69
Fundamental
65
News
53

The reading

Genmab A/S (GMAB) scores 67 out of 100, which reads bullish, higher than 98% of Healthcare stocks and 94% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 69, fundamentals 65.

Among the fundamentals, Free Cash Flow Yield at 100 and Institutional Ownership at 100 score highest, while PEG Ratio at 2 weighs the most against it.

On the daily chart, trend-following indicators average 72 and contrarian oscillators 28 — a split worth reading before trusting the technical total.

News sentiment is neutral at 53; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 40 to 69, and it is up 5 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward GMAB’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

65

Pulling it up

  • Free Cash Flow Yield100

    Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.

  • Institutional Ownership100

    Institutional ownership measures the percentage held by professional investors.

  • Fund Ownership100

    Fund ownership tracks institutional investor holdings and changes.

Holding it back

  • PEG Ratio2

    PEG ratio divides the P/E ratio by earnings growth rate.

  • Earnings Growth (Quarterly)3

    Quarterly earnings growth measures profit increase versus the prior-year quarter.

  • Earnings Growth (Annual)4

    Annual earnings growth tracks year-over-year profit expansion.

39 weighted scorers; 2 had no data today and are left out rather than counted as zero.

Technical · daily

68

Pulling it up

  • Parabolic SAR (PSAR)100

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • VWAP100

    Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

  • EMA 100100

    Exponential Moving Average (100-period) provides a responsive long-term trend view.

Holding it back

  • Bollinger Bands (50)0

    Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • Bollinger Bands (20)1

    Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Williams %R (7)6

    Williams %R (7-period) places the close within the last 7 periods' high-low range.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
53

Technical score by timeframe

ChartScoreWeight
Hourly571
Daily683
Weekly722
Monthly752
Quarterly682

Composite score, last 90 days

05010067Jul 25, 2026Oct 22, 2026Jul 25, 2026: 62Jul 26, 2026: 62Jul 27, 2026: 60Jul 28, 2026: 60Jul 29, 2026: 40Jul 30, 2026: 40Jul 31, 2026: 41Aug 2, 2026: 54Aug 3, 2026: 58Aug 5, 2026: 60Aug 6, 2026: 60Aug 7, 2026: 67Aug 8, 2026: 67Aug 9, 2026: 67Aug 10, 2026: 66Aug 11, 2026: 67Aug 12, 2026: 67Aug 13, 2026: 67Aug 14, 2026: 67Aug 15, 2026: 67Aug 16, 2026: 67Aug 17, 2026: 67Aug 18, 2026: 67Aug 19, 2026: 67Aug 20, 2026: 66Aug 22, 2026: 67Aug 23, 2026: 67Aug 24, 2026: 66Aug 25, 2026: 67Aug 26, 2026: 67Aug 27, 2026: 67Aug 28, 2026: 66Aug 29, 2026: 66Aug 30, 2026: 66Aug 31, 2026: 66Sep 1, 2026: 67Sep 2, 2026: 67Sep 3, 2026: 69Sep 4, 2026: 65Sep 5, 2026: 66Sep 6, 2026: 66Sep 7, 2026: 66Sep 8, 2026: 66Sep 9, 2026: 65Sep 10, 2026: 63Sep 11, 2026: 64Sep 12, 2026: 65Sep 13, 2026: 65Sep 14, 2026: 64Sep 15, 2026: 66Sep 16, 2026: 66Sep 17, 2026: 67Sep 18, 2026: 66Sep 19, 2026: 66Sep 20, 2026: 66Sep 21, 2026: 66Sep 22, 2026: 67Sep 23, 2026: 67Sep 24, 2026: 66Sep 25, 2026: 66Sep 26, 2026: 66Sep 27, 2026: 66Sep 28, 2026: 66Sep 29, 2026: 66Sep 30, 2026: 66Oct 1, 2026: 64Oct 2, 2026: 64Oct 3, 2026: 64Oct 4, 2026: 64Oct 5, 2026: 66Oct 6, 2026: 67Oct 7, 2026: 66Oct 8, 2026: 65Oct 9, 2026: 66Oct 10, 2026: 67Oct 11, 2026: 67Oct 12, 2026: 67Oct 13, 2026: 65Oct 14, 2026: 65Oct 15, 2026: 66Oct 16, 2026: 65Oct 17, 2026: 66Oct 18, 2026: 66Oct 19, 2026: 67Oct 20, 2026: 68Oct 21, 2026: 68Oct 22, 2026: 67
Show the daily numbers
DateComposite
Oct 22, 202667
Oct 21, 202668
Oct 20, 202668
Oct 19, 202667
Oct 18, 202666
Oct 17, 202666
Oct 16, 202665
Oct 15, 202666
Oct 14, 202665
Oct 13, 202665
Oct 12, 202667
Oct 11, 202667
Oct 10, 202667
Oct 9, 202666
Oct 8, 202665
Oct 7, 202666
Oct 6, 202667
Oct 5, 202666
Oct 4, 202664
Oct 3, 202664
Oct 2, 202664
Oct 1, 202664
Sep 30, 202666
Sep 29, 202666
Sep 28, 202666
Sep 27, 202666
Sep 26, 202666
Sep 25, 202666
Sep 24, 202666
Sep 23, 202667
Sep 22, 202667
Sep 21, 202666
Sep 20, 202666
Sep 19, 202666
Sep 18, 202666
Sep 17, 202667
Sep 16, 202666
Sep 15, 202666
Sep 14, 202664
Sep 13, 202665
Sep 12, 202665
Sep 11, 202664
Sep 10, 202663
Sep 9, 202665
Sep 8, 202666
Sep 7, 202666
Sep 6, 202666
Sep 5, 202666
Sep 4, 202665
Sep 3, 202669
Sep 2, 202667
Sep 1, 202667
Aug 31, 202666
Aug 30, 202666
Aug 29, 202666
Aug 28, 202666
Aug 27, 202667
Aug 26, 202667
Aug 25, 202667
Aug 24, 202666
Aug 23, 202667
Aug 22, 202667
Aug 20, 202666
Aug 19, 202667
Aug 18, 202667
Aug 17, 202667
Aug 16, 202667
Aug 15, 202667
Aug 14, 202667
Aug 13, 202667
Aug 12, 202667
Aug 11, 202667
Aug 10, 202666
Aug 9, 202667
Aug 8, 202667
Aug 7, 202667
Aug 6, 202660
Aug 5, 202660
Aug 3, 202658
Aug 2, 202654
Jul 31, 202641
Jul 30, 202640
Jul 29, 202640
Jul 28, 202660
Jul 27, 202660
Jul 26, 202662
Jul 25, 202662

Key facts

Market cap
$24.6B
Sector
Healthcare
Industry
Biotechnology
Beta
0.65
Risk grade (1–10)
—
Next earnings
Nov 5, 2026

Biotechnology peers

CompanyMarket capScore
RPRX Royalty Pharma$36.8B60
ALNY Alnylam Pharmaceuticals$30.4B54
ROIV Roivant Sciences$27.1B48
INCY Incyte$23.7B67
BNTX BioNTech SE$22.5B34
INSM Insmed$20.8B41

Questions

What is GMAB's stock score today?

GMAB scores 67/100 (Bullish) as of Oct 22, 2026: technical 69, fundamental 65, and news sentiment 53, which is shown but not counted. Scores are recomputed every night.

Is GMAB a buy?

The score is not a buy or sell recommendation. A 67 says the technical and fundamental signals we measure lean bullish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the GMAB score calculated?

101 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.